EBRD — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Causaly builds an agentic AI platform for life sciences R&D that retrieves and reasons over scientific evidence, using a scientific knowledge graph and specialized AI agents to support target identification, indication discovery, and regulatory evidence validation.
AI & Machine LearningBiotechHealthtechLondon
Yiannis Kiachopoulos(Founder)inArtur Saudabayev(Executive Officer, Director)Joannis Kiahopoulos(Executive Officer, Director)
BoardMarc Moens(Director)Georgios Tziralis(Director)Carlos Gonzalez-Cadenas(Director)in
Co-investorsEBRD Venture Capital Investment ProgrammeEmerge EducationICONIQIndex VenturesMarathon Venture CapitalPentech Ventures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.